🇺🇸 FDA
Pipeline program

Carboplatin plus Paclitaxel

UW 24-746

Phase 2 small_molecule active

Quick answer

Carboplatin plus Paclitaxel for Ovarian Cancer is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Ovarian Cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials